News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Delaney Brendan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/02/2023 |
4
| Delaney Brendan (See remarks) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Granted 235,000 options to buy
@ $10.93, valued at
$2.6M
|
|
| 01/04/2023 |
4
| Delaney Brendan (See remarks) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Granted 150,000 options to buy
@ $12.31, valued at
$1.8M
|
|
| 09/27/2022 |
4
| Delaney Brendan (COO) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Granted 20,000 shares
@ $12.5, valued at
$250k
|
|
| 04/05/2022 |
4
| Delaney Brendan (COO) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Granted 61,000 options to buy
@ $17.24, valued at
$1.1M
|
|
| 09/22/2021 |
4
| Delaney Brendan (COO) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Granted 260,000 options to buy
@ $29.09, valued at
$7.6M
|
|
| 10/23/2020 |
4
| Delaney Brendan (Chief Commercial Officer) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Disposed/sold 390,460 options to buy
@ $0 |
|
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2019 |
4
| Delaney Brendan (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Granted 51,320 options to buy
@ $17.94, valued at
$920.7k
Granted 25,660 options to buy
@ $17.94, valued at
$460.3k
|
|
| 09/18/2018 |
4
| Delaney Brendan (Chief Commercial Officer) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Granted 44,400 options to buy
@ $22.27, valued at
$988.8k
|
|
| 11/14/2017 |
4
| Delaney Brendan (Chief Commercial Officer) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Granted 150,000 options to buy
@ $12.4, valued at
$1.9M
|
|
|
|